Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?

Matijs van Meurs1, Philipp Kümpers, Jack J M Ligtenberg

  • 1Department of Critical Care, University Medical Center Groningen, University of Groningen, 9700RB Groningen, The Netherlands.

Insights

Multiple organ dysfunction syndrome (MODS) is a critical condition with high mortality. Understanding the angiopoietin/Tie2 system

Area of Science:

  • Critical care medicine
  • Vascular biology
  • Pathophysiology

Background:

  • Multiple organ dysfunction syndrome (MODS) is a severe condition with high mortality, often resulting from sepsis, trauma, or surgery.
  • The exact pathophysiological mechanisms of MODS remain unclear, despite research into inflammation, immunoparesis, and oxygen debt.
  • The endothelium plays a crucial role in MODS, interfacing with inflammation, coagulation, and hemodynamic systems.

Purpose of the Study:

  • To review the angiopoietin/Tie2 signalling system.
  • To discuss the role of this system in critically ill patients.
  • To explore the potential of angiopoietin/Tie2 as a therapeutic target for MODS.

Main Methods:

  • Literature review focusing on the angiopoietin/Tie2 signalling pathway.
  • Analysis of existing data on critically ill patients.
  • Synthesis of information regarding endothelial function in MODS.

Main Results:

  • The angiopoietin/Tie2 system is an important regulator of endothelial function.
  • This system is implicated in the complex pathophysiology of MODS.
  • Current understanding suggests potential therapeutic applications.

Conclusions:

  • The angiopoietin/Tie2 signalling system is a key player in endothelial regulation during critical illness.
  • Further research into this pathway may reveal novel therapeutic strategies for MODS.
  • Targeting the angiopoietin/Tie2 system offers a promising avenue for improving outcomes in critically ill patients.